AIMIL - BGR34
CSIR (Govt. of India)
CSIR-National Botanical Research Institute, Lucknow and CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow took an initiative to develop a promising, safe, non-toxic drug regime to help effectively maintain normal blood glucose levels and reduce the chances of long term complications. The invention provides a novel synergistic herbal formulation for management of diabetes. Formulation comprises of medicinal plant extracts together with the conventional additives to the oral dosage forms, which includes the traditional plant extracts and processing.
NBRI-CIMAP SCIENTISTS EFFORTS
It has been highly commendable on the part of scientists at CSIR-NBRI and CSIR-CIMAP to have in depth research studies to evolve scientifically the most desirable formulation that has been validated experimentally to address the disorder with a difference and that too in completely patient friendly manner. Not only that, the product also imparts the much needed good quality life in the patients.
TECHNOLOGY TRANSFERRED TO
The know how for the product has been transferred to Aimil Pharmaceuticals, the organization well known for its innovative quality products for various therapeutic groups in herbal/ayurvedic sector with a strong marketing network spread throughout the country. We wish Aimil Pharmaceuticals all the success in their noble endeavor of serving the mankind by making the benefits of the marvelous research available to the fast increasing number of the patients all throughout the country.